About: Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli
Creator	Esaam, Aliaa Abdelhamid, Ahmed Hazaa, Mahmoud
Source	PMC
abstract	The sharp increase in antibiotic resistance imposes a global threat to human health and the discovery of effective antimicrobial alternatives is needed. The use of probiotics to combat bacterial pathogens has gained a rising interest. Pathogenic Escherichia coli is causative of multiple clinical syndromes such as diarrheal diseases, meningitis and urinary tract infections. In this work, we evaluated the efficacy of probiotics to control multidrug-resistant E. coli and reduce their ability to form biofilms. Six E. coli resistant to at least five antibiotics (Ceftazidime, Ampicillin, Clarithromycin, Amoxicillin + Clavulanic Acid and Ceftriaxone) were isolated in this work. Preparations of cell-free spent media (CFSM) of six probiotics belonging to the genus Bifidobacterium and Lactobacillus which were grown in Man-Rogosa-Sharpe (MRS) broth exhibited strong antibacterial activity (inhibition zones of 11.77–23.10 mm) against all E. coli isolates. Two E. coli isolates, namely E. coli WW1 and IC2, which were most resistant to all antibiotics were subjected to antibiofilm experiments. Interestingly, the CFSM of MRS fermented by all probiotics resulted in inhibition of biofilm formation while B. longum caused highest inhibition (57.94%) in case of E. coli IC2 biofilms and L. plantarum was responsible for 64.57% reduction of E. coli WW1 biofilms. On the other hand, CFSM of skim milk fermented by L. helveticus and L. rhamnosus exhibited a slight inhibitory activity against IC2 isolate (inhibition percentage of 31.52 and 17. 68, respectively) while WW1 isolate biofilms was reduced by CFSM of milk fermented by B. longum and L. helveticus (70.81 and 69.49 reduction percentage, respectively). These results support the effective use of probiotics as antimicrobial alternatives and to eradicate biofilms formed by multidrug-resistant E. coli.
has issue date	2018-03-12(xsd:dateTime)
bibo:doi	10.1016/j.jsps.2018.03.004
bibo:pmid	29991904
has license	cc-by-nc-nd
sha1sum (hex)	fdb66dfc7edf5a86eb121409bf6db0c0c59eded7
schema:url	https://doi.org/10.1016/j.jsps.2018.03.004
resource representing a document's title	Cell free preparations of probiotics exerted antibacterial and antibiofilm activities against multidrug resistant E. coli
has PubMed Central identifier	PMC6035330
has PubMed identifier	29991904
schema:publication	Saudi Pharm J
resource representing a document's body	covid:fdb66dfc7edf5a86eb121409bf6db0c0c59eded7#body_text
is schema:about of	named entity 'IC2' named entity 'ACTIVITY' named entity 'AMOXICILLIN' named entity 'ISOLATES' named entity 'ANTIBIOTICS' named entity 'ANTIBACTERIAL' named entity 'NEEDED' named entity 'CLARITHROMYCIN' named entity 'HAND' named entity 'REDUCED' named entity 'MEDIA' named entity 'E. COLI' named entity 'INTEREST' named entity 'BROTH' named entity 'THEIR' named entity 'THREAT' named entity 'CEFTRIAXONE' named entity 'MENINGITIS' named entity 'LACTOBACILLUS' named entity 'EVALUATED' named entity 'URINARY TRACT INFECTIONS' named entity 'CELL' named entity 'CAUSED' named entity 'EFFICACY' named entity 'EFFECTIVE' named entity 'STRONG' named entity 'EXPERIMENTS' named entity 'SUPPORT' named entity 'Ceftriaxone' named entity 'eradicate' named entity 'E. coli' named entity 'biofilms' named entity 'resistant' named entity 'MRS' named entity 'ability' named entity 'probiotics' named entity 'gained' named entity 'E. coli' named entity 'ANTIBACTERIAL' named entity 'HIGHEST' named entity 'MAN' named entity 'BACTERIAL PATHOGENS' named entity 'FREE' named entity 'CELL FREE' named entity 'SHARP' named entity 'RESISTANT' named entity 'USE OF' named entity 'PERCENTAGE' named entity 'INHIBITION' named entity 'INHIBITORY ACTIVITY' named entity 'ACTIVITIES' named entity 'RESISTANT' named entity 'PROBIOTICS' named entity 'E. COLI' named entity 'EXERTED' named entity 'SKIM MILK' named entity 'ANTIBIOTIC RESISTANCE' named entity 'THESE' named entity 'BELONGING' named entity 'FERMENTED' named entity 'MULTIPLE' named entity '2857' named entity 'PATHOGENIC' named entity 'MILK' named entity 'REDUCTION' named entity 'GLOBAL' named entity 'ISOLATE' named entity 'BIFIDOBACTERIUM' named entity 'FORMED' named entity 'DIARRHEAL DISEASES' named entity 'RESISTANT TO' named entity 'MRS' named entity 'RESULTS' named entity 'TO CONTROL' named entity 'REDUCE' named entity 'ANTIMICROBIAL' named entity 'RESPONSIBLE' named entity 'WORK' named entity 'GAINED'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software